News
Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution.
The manufacturer of the electronic artificial urinary sphincter aims to develop its device for treating urinary incontinence.
The integration is aimed at boosting data collection.
The new research collaboration will zero in on athletes across Pac-12 universities.
This comes just a week after news broke that Bright Health plans IPO.
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.
The technology release launches the delayed MedTech Funding Mandate that accelerates uptake of innovative treatments and therapies.
The company first collaborated with HSE on a pilot programme for psychological services in 2018.